Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Scala

Showing results (41-50 of 124) with videos related to

Pageof 13
Sort By:
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 28, 2020
Prognostic and Predictive Role of CXC Chemokine Receptor 4 in Metastatic Colorectal Cancer PatientsAlessandro Ottaiano, Stefania Scala, Nicola Normanno, et al.
Open Biology|December 9, 2016
Tumour biomarkers: homeostasis as a novel prognostic indicatorMichela Falco, Giuseppe Palma, Domenica Rea, et al.
Journal of Radiation Research|September 29, 2012
Radiation therapy following surgery for localized breast cancer: outcome prediction by classical prognostic factors and approximated genetic subtypesRoberto Pacelli, Manuel Conson, Laura Cella, et al.
European Journal of Heart Failure|January 6, 2012
Detection, monitoring, and management of trastuzumab-induced left ventricular dysfunction: an actual challengeCarlo G Tocchetti, Gianluca Ragone, Carmela Coppola, et al.
Biochemical Pharmacology|November 4, 2009
Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1Zhongxing Liang, Hui Wu, James Xia, et al.
Molecular Biosystems|August 12, 2015
Intrinsically disordered amphiphilic peptides as potential targets in drug delivery vehiclesMarian Vincenzi, Antonella Accardo, Susan Costantini, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 27, 2016
Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma modelLaura Mercurio, Maria Antonietta Ajmone-Cat, Serena Cecchetti, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|January 30, 2014
Peptides targeting chemokine receptor CXCR4: structural behavior and biological binding studiesSusan Costantini, Raffaele Raucci, Giovanni Colonna, et al.
International Journal of Molecular Sciences|June 2, 2015
Conformational ensembles explored dynamically from disordered peptides targeting chemokine receptor CXCR4Marian Vincenzi, Susan Costantini, Stefania Scala, et al.
Scientific Reports|June 2, 2017
A novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumorsSara Santagata, Luigi Portella, Maria Napolitano, et al.
Pageof 13

Showing results (41-50 of 124) with videos related to

Sort By:
Pageof 13
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 28, 2020
Prognostic and Predictive Role of CXC Chemokine Receptor 4 in Metastatic Colorectal Cancer PatientsAlessandro Ottaiano, Stefania Scala, Nicola Normanno, et al.
Open Biology|December 9, 2016
Tumour biomarkers: homeostasis as a novel prognostic indicatorMichela Falco, Giuseppe Palma, Domenica Rea, et al.
Journal of Radiation Research|September 29, 2012
Radiation therapy following surgery for localized breast cancer: outcome prediction by classical prognostic factors and approximated genetic subtypesRoberto Pacelli, Manuel Conson, Laura Cella, et al.
European Journal of Heart Failure|January 6, 2012
Detection, monitoring, and management of trastuzumab-induced left ventricular dysfunction: an actual challengeCarlo G Tocchetti, Gianluca Ragone, Carmela Coppola, et al.
Biochemical Pharmacology|November 4, 2009
Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1Zhongxing Liang, Hui Wu, James Xia, et al.
Molecular Biosystems|August 12, 2015
Intrinsically disordered amphiphilic peptides as potential targets in drug delivery vehiclesMarian Vincenzi, Antonella Accardo, Susan Costantini, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 27, 2016
Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma modelLaura Mercurio, Maria Antonietta Ajmone-Cat, Serena Cecchetti, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|January 30, 2014
Peptides targeting chemokine receptor CXCR4: structural behavior and biological binding studiesSusan Costantini, Raffaele Raucci, Giovanni Colonna, et al.
International Journal of Molecular Sciences|June 2, 2015
Conformational ensembles explored dynamically from disordered peptides targeting chemokine receptor CXCR4Marian Vincenzi, Susan Costantini, Stefania Scala, et al.
Scientific Reports|June 2, 2017
A novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumorsSara Santagata, Luigi Portella, Maria Napolitano, et al.
Pageof 13